Amgen Cardiovascular. The fight is on. The world’s largest biotech company is taking on the world’s biggest killer—cardiovascular disease. Amgen has the brilliant minds, the proven track record, the deep resources, and the bright future to confidently move into this arena. Their first foray into the cardiovascular realm was sure to be exciting after their previous stunning victories in oncology and immunology. Amgen employees are among the most passionate in the world, so we told the story through their voices. This project was undertaken with DDB Remedy.